Evaluating the research parameters available on the Sysmex® XN-series hematology analyzers as markers of dysplasia in peripheral bloodVicente Aguaderoon March 31, 2025 at 10:00 am
Adv Lab Med. 2025 Feb 4;6(1):98-102. doi: 10.1515/almed-2025-0003. eCollection 2025 Mar. ABSTRACT OBJECTIVES: Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders characterized by peripheral blood cytopenias, cellular dysplasia and risk for progression into acute leukemia. Recent studies reveal that some research parameters available on Sysmex XN-1000® hematology analyzers, including immature platelet fraction (IPF), Neutrophil Granularity Index … Read more